Autoantibodies against <scp>TIF</scp>‐1‐γ and <scp>CADM</scp>‐140 in Spanish patients with clinically amyopathic dermatomyositis (<scp>CADM</scp>): clinical significance and diagnostic utility

Abstract

There is an association between cancer-associated myositis and interstitial lung diseases and their hallmark autoantibodies in our cohort. In addition, the combined determination of myositis-specific autoantibodies and SSA autoantibodies may help to accurately discriminate SCLE from CADM.